Rifamycin S, a quinone and an antibiotic against Gram-positive bacteria (including MRSA), is a clinical drug used to treat tuberculosis and leprosy. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation.
[1] Huiqin Huang, et al. Antonie Van Leeuwenhoek. 2009 Feb;95(2):143-8. [2] D N Rao, A I Cederbaum. Free Radic Biol Med. 1997;22(3):439-46.
















